Literature DB >> 30177343

Widespread white-matter microstructure integrity reduction in first-episode schizophrenia patients after acute antipsychotic treatment.

Linghui Meng1, Kaiming Li2, Wenbin Li3, Yuan Xiao3, Su Lui3, John A Sweeney4, Qiyong Gong5.   

Abstract

Potential effects of initiating acute antipsychotic treatment on white matter (WM) microstructure in schizophrenia patients remain poorly characterized. Thirty-five drug-naïve first-episode schizophrenia patients were scanned before and after six weeks of treatment with second-generation antipsychotic medications. Nineteen demographically matched healthy subjects were scanned twice over the same time interval. Tract-based spatial statistics was used to test for changes in WM microstructural integrity after treatment. Widespread fractional anisotropy (FA) decrease was found in patients after antipsychotic treatment in bilateral posterior corona radiata, anterior corona radiata, superior corona radiata and posterior thalamic radiation, left posterior limb of the internal capsule, and mid-body of the corpus callosum. These effects appeared to result primarily from decreased axial diffusivity. These findings suggest an effect on brain white matter from acute antipsychotic therapy in schizophrenia.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antipsychotics; Drug-naïve; First-episode schizophrenia; Microstructural integrity; Psychoradiology

Mesh:

Substances:

Year:  2018        PMID: 30177343     DOI: 10.1016/j.schres.2018.08.021

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Tract-specific white matter microstructural alterations in subjects with schizophrenia and unaffected first-degree relatives.

Authors:  Sangma Xie; Junjie Zhuo; Ming Song; Congying Chu; Yue Cui; Yunchun Chen; Huaning Wang; Lihua Li; Tianzi Jiang
Journal:  Brain Imaging Behav       Date:  2022-06-22       Impact factor: 3.224

2.  Micro- and Macrostructural White Matter Integrity in Never-Treated and Currently Unmedicated Patients With Schizophrenia and Effects of Short-Term Antipsychotic Treatment.

Authors:  Nina Vanessa Kraguljac; Thomas Anthony; Frank Michael Skidmore; Jon Marstrander; Charity Johanna Morgan; Meredith Amanda Reid; David Matthew White; Ripu Daman Jindal; Nicholas Harry Melas Skefos; Adrienne Carol Lahti
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-01-23

3.  Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations.

Authors:  Yuan Xiao; Wei Liao; Zhiliang Long; Bo Tao; Qiannan Zhao; Chunyan Luo; Carol A Tamminga; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Elliot S Gershon; Elena I Ivleva; Sarah K Keedy; Bharat B Biswal; Andrea Mechelli; Rebekka Lencer; John A Sweeney; Su Lui; Qiyong Gong
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

4.  Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.

Authors:  Johanna Seitz-Holland; Suheyla Cetin-Karayumak; Matcheri Keshavan; Marek Kubicki; Joanne D Wojcik; Amanda Lyall; James Levitt; Martha E Shenton; Ofer Pasternak; Carl-Fredrik Westin; Madhura Baxi; Sinead Kelly; Raquelle Mesholam-Gately; Mark Vangel; Godfrey Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Yogesh Rathi
Journal:  Mol Psychiatry       Date:  2021-01-22       Impact factor: 13.437

5.  Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia.

Authors:  Mi Yang; Shan Gao; Xiangyang Zhang
Journal:  Transl Psychiatry       Date:  2020-11-02       Impact factor: 6.222

6.  Alterations of cerebellar white matter integrity and associations with cognitive impairments in schizophrenia.

Authors:  Xuebin Chang; Xiaoyan Jia; Yulin Wang; Debo Dong
Journal:  Front Psychiatry       Date:  2022-09-26       Impact factor: 5.435

7.  A 16-week randomized placebo-controlled trial investigating the effects of omega-3 polyunsaturated fatty acid treatment on white matter microstructure in recent-onset psychosis patients concurrently treated with risperidone.

Authors:  Amanda E Lyall; Felix L Nägele; Ofer Pasternak; Juan A Gallego; Anil K Malhotra; Robert K McNamara; Marek Kubicki; Bart D Peters; Delbert G Robinson; Philip R Szeszko
Journal:  Psychiatry Res Neuroimaging       Date:  2020-11-04       Impact factor: 2.376

Review 8.  The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies.

Authors:  Chengmin Yang; Jing Tang; Naici Liu; Li Yao; Mengyuan Xu; Hui Sun; Bo Tao; Qiyong Gong; Hengyi Cao; Wenjing Zhang; Su Lui
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

9.  Microstructural white matter abnormalities in pediatric and adult obsessive-compulsive disorder: A systematic review and meta-analysis.

Authors:  Qian Li; Youjin Zhao; Zixuan Huang; Yi Guo; Jingyi Long; Lekai Luo; Wanfang You; John A Sweeney; Fei Li; Qiyong Gong
Journal:  Brain Behav       Date:  2020-12-03       Impact factor: 3.405

10.  Improving the predictive potential of diffusion MRI in schizophrenia using normative models-Towards subject-level classification.

Authors:  Doron Elad; Suheyla Cetin-Karayumak; Fan Zhang; Kang Ik K Cho; Amanda E Lyall; Johanna Seitz-Holland; Rami Ben-Ari; Godfrey D Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David J Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim J Crow; Anthony James; Aristotle N Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Matcheri S Keshavan; Martha E Shenton; Yogesh Rathi; Sylvain Bouix; Nir Sochen; Marek R Kubicki; Ofer Pasternak
Journal:  Hum Brain Mapp       Date:  2021-07-29       Impact factor: 5.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.